Synta Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Synta Pharmaceuticals

SNTA 0.343

+26.6%

Jul 22 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	6/28/2012 10:36:07 AM
	Read Replies (1) of 112

Surprised no one is talking about the interim GALAXY data for ganetsepib, which look a bit iffy compared to the talk that sent the stock on its recent run. ir.syntapharma.com Being interim data, it's too incomplete to be sure, but the might have a subset to go after here. Also, isn't this the first mention that enrollment in the the non-adenocarcinoma arm had been stopped? Material? Whatever, not the triple investors apparently expected, so the stock is giving back a good chunk of the recent run. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next